{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-002748","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.531753+00:00","generated_at":"2026-05-16T10:57:01.786119+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Century Therapeutics updates investor presentation focused on T1D pipeline; no specific new data disclosed","bullets":["Filed updated slide presentation under Item 7.01 used in investor meetings, dated January 12, 2026.","Presentation titled 'Unlocking the Value of our Pipeline for T1D' signals strategic focus on type 1 diabetes.","Available text contains only cover slide and forward-looking statements; no new clinical or financial details visible.","No changes to guidance, pipeline milestones, or financial outlook were provided in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-002748","json":"https://secwatch.observer/filing/0001104659-26-002748.json","markdown":"https://secwatch.observer/filing/0001104659-26-002748.md","text":"https://secwatch.observer/filing/0001104659-26-002748.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465926002748/0001104659-26-002748-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465926002748/tm262422d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:57:01.786119+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}